Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Aya Fukuizumi"'
Autor:
Yuto Terashima, Masaru Matsumoto, Saeko Ozaki, Michiko Nakagawa, Shun Nakagome, Yasuhiro Terasaki, Hiroki Iida, Ryotaro Mitsugi, Eri Kuramochi, Naoko Okada, Tomoyasu Inoue, Satoru Matsuki, Shingo Kitagawa, Aya Fukuizumi, Naomi Onda, Susumu Takeuchi, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
A 73-year-old man with lung squamous cell carcinoma was administered carboplatin + nab-paclitaxel + pembrolizumab for four cycles. Subsequently, he presented with multiple purpuras on his extremities, joint swelling on his fingers, abdominal pain, an
Externí odkaz:
https://doaj.org/article/356b84b7dca94049a8e2fdbe30a368df
Autor:
Yuto Terashima, MD, Masaru Matsumoto, MD, PhD, Hiroki Iida, MD, Sae Takashima, MD, Aya Fukuizumi, MD, PhD, Susumu Takeuchi, MD, PhD, Akihiko Miyanaga, MD, PhD, Yasuhiro Terasaki, MD, PhD, Kazuo Kasahara, MD, PhD, Masahiro Seike, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 11, Pp 100578- (2023)
Introduction: Pervious studies reported the association of TTF-1 expression with the efficacy of platinum-doublet chemotherapy in combination with immune checkpoint inhibitors in advanced nonsquamous NSCLC. Nevertheless, the predictive value of exten
Externí odkaz:
https://doaj.org/article/a8d24f9941d1407ebf190954c5f35839
Autor:
Miwako Omori, Rintaro Noro, Masahiro Seike, Kuniko Matsuda, Mariko Hirao, Aya Fukuizumi, Natsuki Takano, Akihiko Miyanaga, Akihiko Gemma
Publikováno v:
Thoracic Cancer, Vol 13, Iss 15, Pp 2142-2151 (2022)
Abstract Background Small cell lung cancer (SCLC) is a highly aggressive disease with a poor prognosis. Although most patients initially respond to topoisomerase inhibitors, resistance rapidly emerges. The aim, therefore, is to overcome resistance to
Externí odkaz:
https://doaj.org/article/67ccadb8f9304be1b1ff18d17e4b8dec
Autor:
Aya Fukuizumi, MD, Rintaro Noro, MD, PhD, Masahiro Seike, MD, PhD, Akihiko Miyanaga, MD, PhD, Yuji Minegishi, MD, PhD, Miwako Omori, MD, Mamiko Hirao, Kuniko Matsuda, Shinobu Kunugi, MD, PhD, Kazutaka Nishiwaki, Masahiro Morimoto, Haruka Motohashi, Hayato Ohwada, PhD, Jitsuo Usuda, MD, PhD, Akihiko Gemma, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100232- (2021)
Introduction: To investigate the genomic profiles of patients with lung cancer with idiopathic pulmonary fibrosis (IPF-LC), mechanism of carcinogenesis, and potential therapeutic targets. Methods: We analyzed 29 matched, surgically resected, cancerou
Externí odkaz:
https://doaj.org/article/790906db2fa7483283e2b97f1365bd03
Autor:
Tetsuya Kojima, Yuka Fujita, Shinsuke Yamanda, Tomohiro Sakakibara, Toshiro Suzuki, Toshihiko Hino, Yusuke Okuma, Kunihiko Kobayashi, Aya Fukuizumi, Toshihiro Nukiwa, Kazunari Tateishi, Eisaku Miyauchi, Shunichiro Iwasawa, Hisao Imai, Ryo Ko, Kazuhisa Takahashi, Takehito Shukuya, Toshiyuki Harada, Satoshi Morita
Publikováno v:
Lung Cancer. 148:122-128
Background Thymic malignancies are a model of rare cancer. However, little clinical data is available based on the large database. We aimed to clarify the prognostic factors, particularly the metastatic sites, for thymic malignancies using one of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd2a28878a71570e44f74533b81ffb8
https://doi.org/10.1016/j.lungcan.2020.08.014
https://doi.org/10.1016/j.lungcan.2020.08.014
Autor:
Akiko Takahashi, Rintaro Noro, Natsuki Takano, Kakeru Hisakane, Satoshi Takahashi, Aya Fukuizumi, Miwako Omori, Teppei Sugano, Susumu Takeuchi, Shinji Nakamichi, Akihiko Miyanaga, Yuji Minegishi, Kaoru Kubota, Masahiro Seike, Akihiko Gemma
Publikováno v:
Molecular and clinical oncology. 16(4)
Thymic carcinoma is a relatively rare type of malignant tumor. The present retrospective study evaluated the efficacy and safety of carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of advanced thymic carcinoma. The study inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb1144829ba67a8f6ebeadb18f0165aa
https://pubmed.ncbi.nlm.nih.gov/35251638
https://pubmed.ncbi.nlm.nih.gov/35251638
Autor:
Aya Fukuizumi, Rintaro Noro, Masahiro Seike, Akihiko Miyanaga, Yuji Minegishi, Miwako Omori, Mamiko Hirao, Kuniko Matsuda, Shinobu Kunugi, Kazutaka Nishiwaki, Masahiro Morimoto, Haruka Motohashi, Hayato Ohwada, Jitsuo Usuda, Akihiko Gemma
Publikováno v:
Annals of Oncology. 33:S494
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d99f53d4e3fdc3aa47a873b53765c2d
https://doi.org/10.1016/j.annonc.2022.05.149
https://doi.org/10.1016/j.annonc.2022.05.149
Autor:
Aya Fukuizumi1, Akihiko Miyanaga1, Masahiro Seike1 mseike@nms.ac.jp, Yasuhiro Kato1, Shinji Nakamichi1, Kumi Chubachi1, Masaru Matsumoto1, Rintaro Noro1, Yuji Minegishi1, Shinobu Kunugi2, Kaoru Kubota1, Akihiko Gemma1
Publikováno v:
BMC Research Notes. 2015, Vol. 8 Issue 1, p1-5. 5p. 1 Color Photograph, 1 Black and White Photograph, 2 Diagrams.
Autor:
Kaoru Kubota, Aya Fukuizumi, Yuji Minegishi, Mariko Hirao, Masahiro Seike, Satoshi Takahashi, Teppei Sugano, Kuniko Matsuda, Akihiko Miyanaga, Akihiko Gemma, Shinji Nakamichi, Rintaro Noro, Natsuki Takano, Miwako Omori
Publikováno v:
Cancer Research. 80:3068-3068
Small cell lung cancer (SCLC) is a highly aggressive disease with median survival of RNA sequencing was performed using the established cell lines to discover novel therapeutic targets associated with the resistance to topoisomerase inhibitors. We fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1506ef91130ddf18bd90be12e75bf37c
https://doi.org/10.1158/1538-7445.am2020-3068
https://doi.org/10.1158/1538-7445.am2020-3068
Autor:
Akihiko Gemma, Natsuki Takano, Susumu Takeuchi, Kenichiro Atsumi, Arata Azuma, Teppei Sugano, Aya Fukuizumi, Kenichi Kobayashi, Kaoru Kubota, Masahiro Seike, Miwako Omori, Satoshi Takahashi, Yuji Minegishi, Rintaro Noro, Kakeru Hisakane
Publikováno v:
International journal of clinical oncology. 24(12)
Idiopathic interstitial pneumonias (IIPs) are associated with increased risk of lung cancer. In Japan, acute exaberation of IIPs induced by anticancer treatment is a critical issue. For this reason, there is limited available evidence regarding the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a2f46fa307606ff35b5fd6b64d9123
https://pubmed.ncbi.nlm.nih.gov/31352631
https://pubmed.ncbi.nlm.nih.gov/31352631